Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v7-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2024-04-24 | 2024-02-20 |
| Drug Identification Number | 02241837 | 02241837 |
| Brand name | ESTALIS 250/50 MCG | ESTALIS 250/50 MCG |
| Common or Proper name | ESTALIS 250/50 MCG | ESTALIS 250/50 MCG |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | NORETHINDRONE ACETATE ESTRADIOL | NORETHINDRONE ACETATE ESTRADIOL |
| Strength(s) | 250MCG 50MCG | 250MCG 50MCG |
| Dosage form(s) | PATCH | PATCH |
| Route of administration | TRANSDERMAL TRANSDERMAL | TRANSDERMAL TRANSDERMAL |
| Packaging size | 8TTSM | 8TTSM |
| ATC code | G03FA | G03FA |
| ATC description | PROGESTOGENS AND ESTROGENS IN COMBINATION | PROGESTOGENS AND ESTROGENS IN COMBINATION |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2024-01-16 | 2024-01-16 |
| Estimated end date | 2024-04-19 | 2024-04-19 |
| Actual end date | 2024-04-23 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |